In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...
News Medical on MSN8d
Neoantigen vaccine sparks powerful immune defense against kidney cancerA personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
In a phase 1 trial, all 9 patients with renal cell carcinoma treated with a neoantigen-targeting personalized cancer vaccine showed no recurrence at data cutoff.
The absence of kinase activity due to this truncation likely promotes unregulated cell growth, increasing the tumorigenic potential of the cancer cells. 3.4.3 BRCA2 c.3599_3600del Frameshift Mutation ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
Scientists have linked roughly five percent of adult cancers to mutations in genes called FOCAD and TTC37. Another gene known ...
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...
News Medical on MSN3d
Machine learning tool predicts cancer treatment response based on genetic mutationsA groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback